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Trauma- and stress-related disorders are among the most common types of mental
illness affecting the U.S. population. For many of these disorders, there is a striking
sex difference in lifetime prevalence; for instance, women are twice as likely as
men to be affected by posttraumatic stress disorder (PTSD). Gonadal steroids and
their metabolites have been implicated in sex differences in fear and anxiety. One
example, allopregnanolone (ALLO), is a neuroactive metabolite of progesterone that
allosterically enhances GABAA receptor activity and has anxiolytic effects. Like other
ovarian hormones, it not only occurs at different levels in males and females but also
fluctuates over the female reproductive cycle. One brain structure that may be involved in
neuroactive steroid regulation of fear and anxiety is the bed nucleus of the stria terminalis
(BNST). To explore this question, we examined the consequences of augmenting or
reducing ALLO activity in the BNST on the expression of Pavlovian fear conditioning in
rats. In Experiment 1, intra-BNST infusions of ALLO in male rats suppressed freezing
behavior (a fear response) to the conditioned context, but did not influence freezing to
a discrete tone conditioned stimulus (CS). In Experiment 2, intra-BNST infusion of either
finasteride (FIN), an inhibitor of ALLO synthesis, or 17-phenyl-(3α,5α)-androst-16-en-3-
ol, an ALLO antagonist, in female rats enhanced contextual freezing; neither treatment
affected freezing to the tone CS. These findings support a role for ALLO in modulating
contextual fear via the BNST and suggest that sex differences in fear and anxiety could
arise from differential steroid regulation of BNST function. The susceptibility of women to
disorders such as PTSD may be linked to cyclic declines in neuroactive steroid activity
within fear circuitry.
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Introduction
In the U.S., the lifetime prevalence of trauma- and stress-related disorders is 60% greater
for women compared to men (Kessler et al., 2005). Indeed, posttraumatic stress disorder
(PTSD) is twice as likely to occur in women. Sex differences in fear and anxiety have also
been reported in non-human species. One well-established behavioral paradigm that models
aspects of PTSD, Pavlovian fear conditioning, has revealed sex differences in rodents (Maren
et al., 1994; Markus and Zecevic, 1997; Aguilar et al., 2003; Kudo et al., 2004; Wiltgen
et al., 2001; Chang et al., 2009; Gresack et al., 2009; Barker and Galea, 2010; Daviu et al.,
2014) as well as in humans (Milad et al., 2006; Grillon, 2008; Lebrón-Milad et al., 2012).
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In this procedure, a neutral conditioned stimulus (CS, tone) that
has been paired with an aversive unconditioned stimulus (US,
footshock) comes to elicit conditioned fear responses, including
freezing, increases in acoustic startle, and changes in heart rate
and blood pressure (LeDoux, 2000; Maren, 2001; Fanselow and
Poulos, 2005). After fear conditioning, male and female rats show
a dramatic sex difference in levels of contextual freezing: females
express significantly lower levels of freezing in the conditioning
context compared to males (Maren et al., 1994; Markus and
Zecevic, 1997; Barker and Galea, 2010). Interestingly, males and
females exhibit similar levels of freezing during conditioning and
during the expression of fear to the discrete CS (Maren et al.,
1994; Markus and Zecevic, 1997; Barker and Galea, 2010).
One potential neural substrate for this sex difference in
contextual fear is the bed nucleus of the stria terminalis (BNST).
The BNST receives input from multiple limbic structures
involved in emotional processing and sends output directly to
the hub of the hypothalamic-pituitary-axis, the paraventricular
nucleus of the hypothalamus (Crestani et al., 2013). BNST
lesions or inactivation selectively impair freezing to shock-
associated contexts, but not auditory CSs (Hammack et al.,
2004; Sullivan et al., 2004; Resstel et al., 2008; Zimmerman
and Maren, 2011). In addition, BNST inactivation reduces
light- (Walker and Davis, 1997) and corticotropin-releasing
hormone (CRH)-enhanced (Lee and Davis, 1997) startle, two
forms of startle potentiation argued to reflect contextual fear.
BNST lesions also reduce fear to long-duration auditory CSs
that mimic the temporal properties of contextual stimuli
(Waddell et al., 2006). Moreover, recent optogenetic approaches
have shown that discrete neural circuits within the BNST
are involved in regulating responses to aversive contexts
(Jennings et al., 2013; Kim et al., 2013). Collectively, these
data suggest that the BNST is central for the expression
of conditional fear responses, including freezing, to aversive
contexts.
Given its role in reproductive (Claro et al., 1995; Liu et al.,
1997) and maternal (Numan and Numan, 1995, 1996) behaviors,
the BNST is a prime site for hormonal modulation. BNST
neurons have receptors for estrogen (Laflamme et al., 1998),
progesterone (Auger and De Vries, 2002), and androgens; levels
of estrogen and progesterone receptors are similar between
male and female rats whereas levels of androgen receptors are
greater in males (Roselli, 1991). Indeed, hormonal modulation
of BNST activity in fear conditioning has been implicated by
studies of intact cycling females and ovariectomized females
treated with gonadal steroids. For example, natural fluctuations
in ovarian steroids across the estrous cycle are associated
with differences in the expression of contextual fear such that
rats in proestrus, when progesterone and estradiol levels are
highest, show the lowest level of fear compared to males
and females in estrus (Markus and Zecevic, 1997). Moreover,
systemic administration of either progesterone or its neuroactive
metabolite, allopregnanolone (ALLO), impairs CRH-enhanced
increases in acoustic startle, a form of startle that is mediated by
the BNST (Toufexis et al., 2004). A potent allosteric potentiator
of GABAA receptors (Majewska et al., 1986), ALLO has been
linked to reduced anxiety in a variety of other behavioral
paradigms in which female rodents appear less anxious than
males (Frye et al., 2000; Hughes et al., 2004), including the
elevated plus maze (Bitran et al., 1991), the defensive burying test
(Picazo and Fernández-Guasti, 1995), the light/dark transition
test (Wieland et al., 1991), and the open field test (Wieland
et al., 1991). Although ALLO can be synthesized within the
gonads, adrenal glands, and brains of both male and female
rats, it is found in higher concentrations in female brains
and plasma (Corpéchot et al., 1993). In females, ALLO levels
in whole brain and plasma are 8- to 10-fold higher than in
males (Purdy et al., 1990; Corpéchot et al., 1993; Cheney et al.,
1995).
Collectively, this work suggests that ALLO may regulate fear
and anxiety by modulating neuronal activity in the BNST. To
explore this question, we assessed whether augmenting ALLO
activity in the BNST of male rats would decrease contextual
freezing (Experiment 1) and, conversely, whether reduction
of ALLO activity in the BNST of female rats would increase
contextual freezing (Experiment 2). Males received intra-BNST
infusions of ALLO whereas females received infusions of
either an ALLO synthesis inhibitor, finasteride (FIN; Finn
et al., 2006), or a selective antagonist, 17-phenyl-(3α,5α)-
androst-16-en-3-ol (17-PA; Mennerick et al., 2004; Kelley
et al., 2007). Importantly, this set of experiments examines
whether hypothesized sex differences in endogenous intra-
BNST ALLO (i.e., low endogenous ALLO activity in males
and high endogenous ALLO activity in females) contribute to
the contextual fear phenotype in each sex. We now show that
manipulations of ALLO activity within the BNST affect the
expression of contextual fear in both male and female rats,
a finding that supports neuroactive steroid modulation of the
BNST in fear and anxiety.
Materials and Methods
Animals
Male and female Long-Evans rats (200–224 g; Blue Spruce)
were obtained from a commercial supplier (Harlan Laboratories,
Indianapolis, IN, USA). At the time of arrival, rats were
individually housed in clear plastic cages; males and females were
kept in separate rooms. Lights were maintained on a 14:10 h
light:dark cycle (lights on at 7:00 A.M.) with access to food and
water ad libitum. Upon arrival, each rat was handled for 20 s each
day for five consecutive days to acclimate to the experimenter.
All experiments were carried out in accordance with guidelines
approved by the Institutional Animal Care and Use Committees
at Texas A&M University.
Behavioral Apparatus
All behavioral procedures occurred in eight identical observation
chambers (30 × 24 × 21 cm; Med Associates, St. Albans,
VT, USA) composed of aluminum sidewalls and Plexiglas
ceiling, rear wall, and front door. One sidewall contained a
speaker for CS delivery and the other contained an incandescent
house light. Chamber floors consisted of 19 stainless steel rods
(4 mm in diameter) spaced 1.5 cm apart (center to center)
for footshock US delivery. The rods were wired to a shock
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source and solid-state grid scrambler (Med Associates). Beneath
the rods was a removable stainless steel tray. In addition,
each chamber was positioned in a sound-attenuating cabinet
equipped with a ventilation fan to provide background noise
(65 dB).
The behavioral procedures were conducted in two distinct
contexts. For ‘‘context A’’ (conditioning and context test), the
chambers were cleaned with 1% acetic acid; the pans beneath
the floors were also rinsed in acetic acid. The house lights
(15 W) in the chambers were lit and the cabinet doors were
left open. White fluorescent room lights, the computer monitor,
and cabinet fans were on. Animals were transported to and
from the vivarium in white plastic boxes. For ‘‘context B’’ (tone
test), the chambers were cleaned with 1% ammonium hydroxide.
The house lights were turned off and the cabinet doors were
closed. Red fluorescent lights illuminated the room, the computer
monitor was turned off, and the cabinet fans were on. Animals
were transported to and from the vivarium in black plastic
boxes.
Locomotor activity was measured by recording the
displacement of the load cell platform located underneath
each chamber (Maren, 1998). Prior to the experiment, each load
cell amplifier was calibrated to a fixed chamber displacement
with the output of each amplifier set to a specific gain to detect
immobility. The output of the load cell amplifier was digitized
such that one observation every 200 ms for each rat was recorded
via the Threshold Activity software (Med Associates). Freezing
behavior was derived from the locomotor activity as previously
described (Maren, 1998).
Surgery
Male rats were anesthetized with ketamine (100 mg/kg
body weight; i.p.) and xylazine (10 mg/kg body weight;
i.p.) and treated with atropine sulfate (0.04 mg/kg body
weight, i.p.). Female rats were anesthetized with ketamine
(60 mg/kg body weight; i.p.) and xylazine (8 mg/kg body
weight; i.p.) and treated with atropine sulfate (0.04 mg/kg
body weight; i.p.). After shaving the top of the head, each
rat was secured in a stereotaxic apparatus (David Kopf
Instruments, Tujunga, CA, USA). The scalp was incised
and retracted. Head position was adjusted to align lambda
and bregma in the same horizontal plane. Small burr holes
(1 mm in diameter) were drilled bilaterally into the skull for
placement of guide cannulae (stainless steel, 26-gauge, 9 mm
below pedestal; Plastics One, Roanoke, VA, USA) directed
towards the BNST (0.0 mm AP and 2.7 mm ML relative
to bregma, −6.9 mm DV from dura at a 10◦ angle from
vertical towards the midline). In addition, three burr holes
were drilled for the placement of anchoring screws. After
implantation of guide cannulae, dental acrylic was applied
to affix the cannulae to the skull. After surgery, dummy
cannulae (33-gauge, 9 mm with 1-mm projection; Plastics
One) were inserted into the guide cannulae. Rats were allowed
to recover for 1 week before behavioral procedures. To
habituate the animals to the infusion procedures, rats were
individually transported in white 5-gal buckets lined with
bedding to the infusion room (within the vivarium) and received
dummy changes on two separate days during the recovery
period.
Vaginal Smears
Vaginal smears were obtained from all female rats for at least
eight consecutive days to ensure normal cycling; estrous cycle
phase was not used as a variable in the analysis due to sample
size. To track estrous cycle phase, vaginal smears were taken
daily with cotton swabs moistened with distilled water between
8:00 and 10:00 A.M. starting the day of surgery and continuing
throughout the behavioral procedures (allowing for at least 1 h
between smears and behavior). Cells were visualized under a light
microscope at 100× and characterized according to Goldman
et al. (2007). One rat with an irregular cycle was excluded from
the analysis.
Drugs
All drugs were prepared in a 30% (w/v) solution
of the complexing agent hydroxypropyl-β-cyclodextrin
(VEH; Sigma-Aldrich, St. Louis, MO, USA) in purified water.
Allopregnanolone or (3α,5α)-3-hydroxy-pregnan-20-one
(ALLO; R&D Systems, Minneapolis, MN, USA) was solubilized
in VEH (8 mg/ml). The 5α-reductase inhibitor commonly
known as finasteride, (5α,17β)-N-(1,1-dimethylethyl)-3-oxo-
4-azaandrost-1-ene-17-carboxamide (FIN; Sigma-Aldrich),
was solubilized in VEH (10 mg/ml). The steroid antagonist,
17-phenyl-(3α,5α)-androst-16-en-3-ol (17-PA; R&D Systems)
was solubilized in VEH (3.5 mg/ml). Infusions were made
with 10-µl Hamilton syringes mounted into an infusion pump
(KD Scientific, Hollistan, MA, USA) and connected to internal
cannulae (33-gauge, 9 mm with 1-mm projection; Plastics One)
with either polyethylene tubing (PE-20, Braintree Scientific,
Braintree, MA, USA) for VEH or polytetrafluoroethylene tubing
(PTFE; 28-gauge, SAI Infusion Technologies, Lake Villa, IL,
USA) for drugs. PTFE tubing was used to minimize drug loss
due to nonspecific binding.
Procedures
Experiment 1: Effects of ALLO on the Expression
of Contextual and Cued Fear in Male Rats
For the ALLO study, 31 male Long-Evans rats were housed and
cannulated as described above. On Day 1, rats were transported
to the laboratory and placed in the conditioning chambers
(context A) for training. After a 3-min baseline period, rats
were presented with five tone (CS; 10 s, 80 dB, 2 kHz)-shock
(US; 2 s, 1 mA) pairings in which the tone was immediately
followed by the shock. There was a 1-min inter-trial interval
(ITI) between each tone-shock pairing followed by a 1-min wait
period after the final shock. On Day 2, 24 h later, squads of
4 rats were transported to the infusion room in white 5-gal
buckets lined with bedding. Rats received bilateral intra-BNST
infusions (0.25 µl at 0.25 µl/min) of either VEH (n = 15) or
ALLO (2 µg/side; n = 16). The dosage and timing of ALLO
infusions were based on previous reports of behavioral effects
resulting from intracranial infusions (Bitran et al., 1991; Akwa
et al., 1999; Engin and Treit, 2007); BNST infusion volumes
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were based on previous work from our laboratory (Zimmerman
and Maren, 2011). After the 1-min infusion, internal cannulae
were left in place for 2 min to allow for drug diffusion and
then replaced with clean dummy cannulae. Context testing began
ten minutes after the start of infusions. Rats were placed in the
conditioning chambers (context A) for a 10-min context test
in which no tones or shocks were delivered. On Day 3, rats
were infused in the same manner with the same drug as on
Day 2 and, at 10 min after the start of infusions, were placed
in a novel context (context B) for a tone test. The tone test
consisted of a 3-min baseline period followed by four tone (CS;
10 s, 80 dB, 2 kHz) presentations with a 1-min ITI and a 1-min
wait period after the last tone. The conditioning and testing
procedures (including the order of context and tone tests) were
patterned after the experimental designs used in many of our
studies (Maren et al., 1997; Maren, 1998, 1999; Zimmerman and
Maren, 2011), including work revealing sex differences in the
expression of contextual fear (Maren et al., 1994).
Experiment 2: Effects of FIN and 17-PA on the
Expression of Contextual and Cued Fear in
Female Rats
Seventy-six female Long-Evans rats were housed and cannulated
as described above. On Day 1, rats were transported to the
laboratory, placed in the conditioning chambers (context A) and
trained in the samemanner as in Experiment 1. OnDay 2, squads
of 8 rats were transported to the infusion room in white 5-gal
buckets lined with bedding. Rats received bilateral intra-BNST
infusions (0.25 µl at 0.25 µl/min) of VEH, FIN (2.5 µg/side),
or 17-PA (0.875 µg/side). The doses of FIN and 17-PA were
based on previous reports (Frye and Vongher, 2001; Rhodes
and Frye, 2001; Frye and Walf, 2002; Walf et al., 2006; Kelley
et al., 2007; Svensson et al., 2013). After the 1-min infusion,
internal cannulae were left in place for 2 min to allow for
drug diffusion and then replaced with clean dummy cannulae.
Animals receiving FIN infusions (and a subset of VEH controls)
were returned to their home cages for 2 h prior to retrieval testing
to allow sufficient time for 5α-reductase inhibition (Rhodes
and Frye, 2001; Frye and Walf, 2002; Walf et al., 2006). Rats
in the 17-PA group (and a subset of VEH controls) were
tested 10 min after their infusions (Svensson et al., 2013). For
the context testing, rats were transported to the conditioning
chambers (context A) for a 10-min context test as described in
Experiment 1. On Day 3, rats were infused with the same drug
as on Day 2 and were transported to a novel context (context
B) for a tone test as described in Experiment 1. One rat from
the FIN group was excluded due to acyclicity and a squad of
rats (4 VEH and 4 17-PA) was excluded due to an equipment
malfunction. Data from VEH controls for the FIN and 17-PA
groups were collapsed for analysis as they did not differ. This
left group sizes of: VEH (n = 26), FIN (n = 15), and 17-PA
(n = 12).
Histology
After behavioral testing, all rats were overdosed with
pentobarbital (100 mg/kg) and transcardially perfused with
0.9% saline followed by 10% formalin. Brains were rapidly
dissected and post-fixed in 10% formalin for 24 h before transfer
to a 30% sucrose-formalin solution. Brains were sectioned at
40 µm on a cryostat at a constant temperature of −20◦C and
mounted on subbed slides with 70% ethanol. Sections were
stained with 0.25% thionin to visualize cannulae placements
within the BNST.
Data Analysis
In all experiments, the percentage of freezing behavior was
averaged across 1-min blocks in each behavioral session (the 10-s
CS periods were excluded from the analysis of the conditioning
and tone test sessions) and analyzed using analysis of variance
(ANOVA). We hypothesized that across the context tests,
ALLO would reduce freezing in males and FIN and 17-PA
would increase freezing in females. Therefore, a priori planned
comparisons using Fisher’s PLSD test were computed after
significant effects in the ANOVA. All data are represented as
means± SEMs.
Results
Intra-BNST ALLO Infusion and Contextual Fear in
Male Rats
Histology
Of 31 male rats receiving cannulae, nine were excluded because
their cannulae were not centered in the BNST. This yielded the
following group sizes: VEH (n = 9) and ALLO (n = 13). As shown
in Figure 1A, the majority of cannula placements were centered
at 0.26 mm caudal to bregma, although placements both rostral
and caudal to that level were similarly represented.
Behavior
Acquisition of fear conditioning did not differ between male
groups assigned to receive infusions of VEH or ALLO
(Figure 2A). Levels of freezing were low (<10%) prior to
the start of training and increased across the five training
trials similarly for all animals. A repeated measures ANOVA
with a between-subjects variable of drug group (VEH or
ALLO) showed a significant main effect of trial number
(TRIAL) on the level of freezing expressed (F(5,100) = 18.0,
p < 0.0001) but neither the main effect of drug group
(F(1,20) = 1.88, p = 0.19) nor the interaction between
drug group and trial number (F(5,100) = 0.30, p = 0.91)
was found to be significant. Thus, all male rats acquired
conditioned fear at similar rates and levels prior to their drug
manipulations.
Intra-BNST ALLO infusions 10 min prior to testing resulted
in a decreased level of freezing to the conditioned context
for male rats (Figure 2B). A repeated measures ANOVA
with a between-subjects variable of drug group (VEH or
ALLO) showed that intra-BNST infusion of ALLO suppressed
freezing throughout the 10-min context test. The analysis
revealed significant main effects of drug group (F(1,20) = 5.22,
p < 0.05) and time (min 1–10; F(9,180) = 2.08, p < 0.05).
In addition, there was a significant interaction between
drug group and time (F(9,180) = 1.99, p < 0.05). Planned
comparisons (p < 0.05) of the average freezing during each
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FIGURE 1 | Schematic coronal sections showing cannula placements in
the bed nucleus of the stria terminalis (BNST). Cannula placements are
indicated for infusions of vehicle (VEH), allopregnanolone (ALLO), finasteride
(FIN), and 17-phenyl-(3α,5α)-androst-16-en-3-ol (17-PA). Representative
thionin-stained sections are shown below each set. (A) Infusion sites for VEH
(red circles) and ALLO (blue circles) in male rats with photomicrograph of a
representative section. (B) Infusion sites for VEH (red circles), FIN (blue circles),
and 17-PA (green circles) in female rats with photomicrograph of a
representative section. Coronal brain section images adapted from Swanson
(2003).
minute of the context test revealed that ALLO significantly
reduced freezing during minutes 2–5 and minute 7 of the test
(Figure 2B). These data indicate that acute ALLO administration
in the BNST suppressed the expression of contextual fear in
male rats.
By contrast, pre-test infusion of ALLO into the BNST did
not affect conditional freezing during the tone test (Figure 2C).
A repeated measures ANOVA with a between-subjects variable
of drug group (VEH or ALLO) and a within-subject variable
of trial number (TRIAL) revealed a main effect of trial
(F(4,80) = 16.9, p < 0.0001), but there was neither a significant
main effect of drug group (F(1,20) = 0.97, p = 0.34) nor an
interaction between drug group and trial (F(4,80) = 0.50, p = 0.73).
These data indicate that acute ALLO administration in the
BNST produces a selective reduction in contextual freezing in
male rats.
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FIGURE 2 | Conditioned freezing in male rats receiving pre-test
infusions of ALLO into the BNST. (A) Mean percentage of freezing (±SEM)
during the five-trial training session (data are shown with a 3-min pre-trial period
followed by five tone-shock pairings). Freezing was quantified before the first
conditioning trial (baseline, BL) and during the 1-min period after each
conditioning trial. (B) Mean percentage of freezing (±SEM) to context over
10 min 1 day after training. (C) Mean percentage of freezing (± SEM) to four
auditory conditioned stimulus (CS) presentations in a novel context 2 days after
training. Freezing was quantified before the first tone trial (baseline, BL) and
during the 1-min period after each tone trial. *p < 0.05 ALLO vs. VEH.
Intra-BNST Infusion of FIN or 17-PA and
Expression of Contextual Fear in Female Rats
Histology
Of the 67 cycling female rats, 14 were excluded because their
cannulae either missed the target or were not patent (resulting
in a unilateral infusion). This yielded the following group sizes:
VEH (n = 26), FIN (n = 15), and 17-PA (n = 12). As shown
in Figure 1B, the majority of cannula placements were centered
0.26 mm caudal to bregma although there were many placements
rostral and caudal to that level.
Behavior
Acquisition of fear conditioning did not differ between the
females assigned to receive VEH, FIN, or 17-PA (Figure 3A).
Levels of freezing were low prior to the start of training (<5%)
and increased across the five training trials similarly for all
animals. A repeated measures ANOVA with a between-subjects
variable of drug group (VEH, FIN, or 17-PA) and a within-
subject variable of trial (TRIAL) showed a main effect of trial
(F(5,250) = 24.7, p < 0.0001). There was neither a significant
main effect of group (F(2,50) = 0.31, p = 0.74) nor an interaction
between drug group and trial (F(10,250) = 0.98, p = 0.46). Thus,
female rats from all groups acquired conditioned fear at similar
rates and levels prior to their drug manipulations.
As shown in Figure 3B, intra-BNST infusions of either FIN
or 17-PA prior to testing (2 h or 10 min, respectively) modestly,
but significantly, increased levels of freezing to the conditioned
context in female rats. A repeated measures ANOVA with a
between-subjects variable of drug group (VEH, FIN, or 17-PA)
and a within-subject variable of time (min 1–10) revealed a
significant main effect of time (F(9,450) = 14.6, p < 0.0001) and
a significant group X time interaction (F(18,450) = 1.81, p< 0.05).
There was no significant main effect of drug group (F(2,50) = 1.36,
p = 0.27). Inspection of Figure 3B suggested that the significant
group X time interaction in the ANOVA was due to increases
in freezing produced by intra-BNST infusions of FIN and 17-PA
in the early minutes of the context test. This impression was
confirmed by planned comparisons (p< 0.05) of average freezing
during each minute of the context text. These comparisons
revealed that FIN increased freezing relative to VEH-treated rats
during the first 2min of the test; 17-PA increased freezing relative
to VEH controls in minutes 2–4 of the context test. These data
indicate that intra-BNST infusion of an ALLO synthesis inhibitor
(FIN) or an ALLO antagonist (17-PA) enhanced the expression
of contextual freezing in females.
As shown in Figure 3C, pre-test intra-BNST infusions of
either FIN or 17-PA did not affect freezing during the tone
test. A repeated measures ANOVA with a between-subjects
variable of drug group (VEH, FIN, or 17-PA) and a within-
subject variable of trial number (TRIAL) showed a main effect
of trial number (F(4,200) = 68.8, p < 0.0001). There was
neither a significant main effect of drug group (F(2,50) = 0.09,
p = 0.92) nor an interaction between drug group and trial number
(F(8,200) = 0.44, p = 0.90). These data reveal that intra-BNST
infusions of FIN or 17-PA produce a selective enhancement of
contextual freezing in female rats.
Discussion
The present results reveal that manipulations of ALLO activity
within the BNST modulate the expression of conditioned
contextual fear in rats. Consistent with our hypothesis,
endogenous ALLO activity in males and females appears to
contribute to the contextual fear phenotype in each sex. For
males, in which brain ALLO levels are relatively low, augmenting
BNST ALLO levels suppressed the expression of contextual
freezing. In contrast, for females, in which brain ALLO levels are
relatively high, reducing intra-BNSTALLO activity enhanced the
expression of contextual freezing. The effects we observed were
not likely due to nonspecific sensorimotor effects of the BNST
drug manipulations insofar as freezing to the auditory CS was
unaffected by all treatments. Together, our results suggest that
ALLO in the BNST may be a critical modulator of fear behavior
in both male and female rats.
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FIGURE 3 | Conditioned freezing in female rats receiving pre-test
infusions of either FIN or 17-PA into the BNST. (A) Mean percentage
of freezing (± SEM) for all females during the five-trial training session
(data are shown with a 3-min pre-trial period followed by five tone-shock
pairings). Freezing was quantified before the first conditioning trial
(baseline, BL) and during the 1-min period after each conditioning trial.
(B) Mean percentage of freezing (± SEM) to context over 10 min 1 day
after training. (C) Mean percentage of freezing (± SEM) to four auditory
CS presentations in a novel context 2 days after training. Freezing was
quantified before the first tone trial (baseline, BL) and during the 1-min
period after each tone trial. *p < 0.05 FIN vs. VEH, #p < 0.05 17-PA
vs. VEH.
By utilizing ALLO infusions into the brain, our findings
extend previous work linking circulating gonadal steroid levels
to contextual fear in female rats (Markus and Zecevic, 1997;
Toufexis et al., 2004). In these studies, intact female rats that were
conditioned and tested during proestrus, when progesterone
levels are high, exhibited lower levels of contextual freezing
compared to those trained and tested in other phases of
the estrous cycle (Markus and Zecevic, 1997). In addition,
ovariectomized female rats treated with systemic ALLO showed a
significant reduction in CRH-enhanced but not fear-potentiated
acoustic startle (Toufexis et al., 2004). The former is a test of
‘‘sustained’’ or contextual fear whereas the latter is a test of
‘‘phasic’’ or cued fear (Davis et al., 2010). Similar reductions
have been observed in ovariectomized females treated either
acutely or chronically with progesterone (Toufexis et al., 2004).
By contrast, systemic treatment of ovariectomized females with
medroxy-progesterone acetate, a synthetic steroid that binds to
the progesterone receptor but is not metabolized to ALLO, did
not affect levels of CRH-induced startle (Toufexis et al., 2004).
Altogether, these data suggest that the reduced levels of context-
dependent fear observed in females with elevated circulating
progesterone levels may be due to the actions of its metabolite,
ALLO, within the BNST.
Additional evidence supporting ALLO modulation of
contextual fear can be found in studies of socially isolated mice.
Male mice that have been socially isolated for three to four
weeks show elevated levels of context- but not cue-specific fear
(Pibiri et al., 2008). Interestingly, this change in conditioned fear
behavior coincides with decreases in ALLO and 5α-reductase
mRNA within components of the fear circuitry (medial
prefrontal cortex, hippocampus, and basolateral amygdala).
Group-housed mice showed similar increases in contextual
fear following pharmacological blockade of 5α-reductase. This
work lends support to the idea that reduced 5α-reductase
activity in fear circuits can contribute to reduced ALLO levels in
brain and concomitantly elevated contextual fear. We cannot,
however, exclude the possibility that the early effects of FIN on
contextual freezing in females may be due to reduced levels of the
GABAergic potentiators, (3α,5α,17β)-androstane-3, 17-diol (3α-
androstanediol) and (3α,5β)-3, 21-dihydroxypregnan-20-one
(tetrahydrodeoxycorticosterone or THDOC), as 5α-reductase
is involved in the synthesis of these compounds from
17-hydroxyandrostan-3-one (dihydrotestosterone or DHT)
and 11-deoxycorticosterone (deoxycorticosterone or DOC),
respectively (Reddy, 2010).
The results of the current study are consistent with the
widely held view that the BNST is critical for the expression
of contextual fear responses (Sullivan et al., 2004; Zimmerman
and Maren, 2011) and support a role for GABAergic synaptic
transmission therein. Previous work involving infusions of the
GABAergic agonist, muscimol, (Fendt et al., 2003) and a GABA
synthesis inhibitor (Sajdyk et al., 2008) has underscored the
importance of the inhibitory neurotransmitter in regulating fear
and anxiety via the BNST. Here we show for the first time
that ALLO modulation of GABAA receptors in the BNST may
be involved in the regulation of contextual fear. While its use
in behavioral paradigms is quite new, 17-PA has been well-
characterized by in vitro and in vivo studies for its selective
antagonism of ALLO action at GABAA receptors (Mennerick
et al., 2004; Kelley et al., 2007; Svensson et al., 2013). Although
its antagonism of 3α-androstanediol has not been examined,
17-PA has been shown to be ineffective against 5β-reduced
steroids, barbiturates, and benzodiazepines and only partially
effective against THDOC (Mennerick et al., 2004; Kelley et al.,
2007). Thus, the effects of the 5α-reductase inhibitor, FIN, on
contextual fear in females when considered in conjunction with
those of 17-PA provide support for locally available ALLO acting
at GABAA receptors within the BNST.
Recent human studies support links between ALLO, the
BNST, and dysfunctional anxiety. Decreased levels of ALLO in
CSF have been reported in premenopausal women diagnosed
with PTSD compared to healthy individuals although it was
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not known whether this deficiency was pre-existing (Rasmusson
et al., 2006). A context-specific role for the BNST in conditioned
fear may apply to humans. Imaging studies have shown that
nonhuman primates with trait anxious temperament have
increased resting metabolism in the BNST (Oler et al., 2009)
and that trait anxious human subjects exhibit exaggerated
activity in the BNST during threat monitoring (Somerville et al.,
2010), suggesting that ‘‘hypervigilant threat monitoring’’ (akin to
contextual fear) may be a BNST-dependent process.
Nonetheless, the rodent data present a paradox: female rats
with presumably higher levels of circulating ALLO exhibit
less contextual fear and extinguish their fear responses faster
than males, a pattern of results that seemingly contradicts that
observed in human females (Maren et al., 1994; Gupta et al.,
2001; Chang et al., 2009). Namely, although women cyclically
attain higher circulating levels of ALLO than men (Genazzani
et al., 1998), they exhibit a greater susceptibility to PTSD
(Kessler et al., 2005). One answer to this paradox may lie in
the relative propensity of males and females to extinguish fear
once it is acquired. For example, studies in both rats (Gupta
et al., 2001; Chang et al., 2009; Milad et al., 2009; Zeidan
et al., 2011) and humans (Milad et al., 2006, 2009, 2010) reveal
that low but not high estrogen levels in females retard the
extinction of conditioned fear below that observed in males.
Deficits in fear extinction are widely believed to contribute to
the maintenance of PTSD (Pitman et al., 2012; Maren et al.,
2013) and the regulation of fear extinction by gonadal steroids
may be critical to increasing the vulnerability of both female
rats and humans to persistent and pathological fear responding.
Although it is not known how progesterone and its metabolites
contribute to fear extinction, it is also possible that low levels
of ALLO produce a resistance to extinction that contributes
to enduring fear responses thought to underlie PTSD (Pinna,
2014). In socially isolated male mice, systemic administration
of ganaxolone, a synthetic analog of ALLO, has been shown to
facilitate extinction of contextual fear (Pinna and Rasmusson,
2014). Thus, cyclical variation in neuroactive steroid levels in
female rats and humans might promote vulnerabilities to fear
extinction, thereby contributing to disorders such as PTSD. It
should be noted that ganaxolone is currently in clinical trials for
treatment of PTSD1.
In summary, our findings suggest that ALLOwithin the BNST
modulates contextual fear in bothmale and female rats. Although
we cannot speak to the relative contribution of different ALLO
sources (peripheral vs. brain), immunolabeling studies have
shown high levels of cellular staining in the rat BNST by an
anti-ALLO antibody (Saalmann et al., 2007; Cook et al., 2014),
supporting the local availability of this progesterone metabolite.
As previously suggested by systemic administration, ALLO
promotes anxiolytic behavior in response to fear-conditioned
contexts and may account for sex differences observed in
contextual fear. In women, deficiencies or large variations in
circulating and brain ALLO over the reproductive cycle may
contribute to increased vulnerability for anxiety disorders such as
PTSD. Further work on the cellular and molecular mechanisms
of ALLO action in the BNST may yield insight on determinants
of susceptibility to anxiety disorders both within and across
genders and inform on potential avenues of pharmacological
intervention.
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